|1.||Antczak, Adam: 12 articles (08/2015 - 08/2002)|
|2.||Barnes, Peter J: 12 articles (01/2011 - 08/2002)|
|3.||Basu, Samar: 11 articles (01/2007 - 10/2002)|
|4.||Montuschi, Paolo: 9 articles (01/2010 - 08/2002)|
|5.||Górski, Paweł: 8 articles (12/2014 - 01/2010)|
|6.||Ciabattoni, Giovanni: 8 articles (01/2010 - 07/2003)|
|7.||Piotrowski, Wojciech J: 7 articles (07/2012 - 08/2007)|
|8.||Marczak, Jerzy: 7 articles (07/2012 - 08/2007)|
|9.||Ciebiada, Maciej: 6 articles (08/2015 - 12/2010)|
|10.||Bhattacharya, Syamal K: 6 articles (09/2014 - 09/2008)|
|1.||Asthma (Bronchial Asthma)
01/01/2009 - "Exhaled breath condensate (EBC) levels of 8-isoprostane (IsoP), which is a known marker of oxidative stress, might therefore be helpful for monitoring asthma noninvasively. "
06/01/2013 - "The objective of this study was to evaluate EBC 8-isoprostane concentrations following allergen-induced bronchoprovocation in asthma. "
09/01/2009 - "Our study shows that oxidative stress is increased significantly in asthmatic subjects and the degree of oxidative stress in EB subjects is milder than that in asthma, as reflected by 8-isoprostane concentrations in the BAL fluid. "
09/01/2007 - "To investigate changes in oxidant stress during and following acute asthma exacerbations, this study measured 2,3-dinor-5,6-dihydro-15-F(2t)-IsoP (F(2)-IsoP-M), the major urinary metabolite of 15-F(2t)-IsoP, in eight asthmatic adults, during and following an asthma hospitalization. "
02/01/2004 - "Our study shows that EBC cys-LTs and 8-isoprostane concentrations are higher in asthmatic children than in healthy control children, with scattered values in patients with unstable asthma. "
05/01/2003 - "Administration of gammaT led consistently to a significant reduction of inflammation-mediated increase in 8-isoprostane, a biomarker of lipid peroxidation. "
03/01/2005 - "In this study, we investigated the potential role of 8-iso-PGF2alpha in inflammation, focusing on its effects on adhesion of monocytes to microvascular endothelial cells, an early event in the inflammatory response. "
02/01/2013 - "Over four weeks, exhaled breath condensate was collected twice a week from 18 asthmatics and 18 nonasthmatics (ages 14-19 years) attending two New York City schools and analyzed for pH and 8-isoprostane as indicators of airway inflammation and oxidative stress, respectively. "
11/01/2010 - "The strict correlation between cys-LTs and 8-isoprostane underlines the relationship between allergic inflammation and oxidative stress. "
06/01/2008 - "Exhaled breath 8-isoprostane concentrations increased after exposure to CAPs (16.9+/-8.5 vs. 4.9+/-1.2 pg/mL, p<0.05), but markers of systemic inflammation were largely unchanged. "
03/01/2006 - "Analysis of the concentrations of 8-isoprostane and MPO in exhaled breath condensate allows assessment of oxidative stress in the airways of patients with severe lung infections."
11/01/2006 - "Elevation of 8-isoprostane in patients with hepatitis C virus infection undergoing hemodialysis."
05/01/2008 - "In addition, the combination of urinary 15-F(2t)-IsoP above the mean and chronic hepatitis B virus (HBV) infection resulted in an OR of 19.01 (95% CI = 6.67-54.17) compared with those with low urinary 15-F(2t)-IsoP and without HBV infection. "
01/01/2005 - "Successful eradication of H pylori infection led to a significant reduction in both 8-iso-PGF(2alpha) and 11-dehydro-TXB2. "
01/01/2010 - "viverrini infection also increased two to three times in the plasma inflammatory indicators, 8-isoprostane, malondialdehyde, and nitrate/nitrite. "
|4.||Type 2 Diabetes Mellitus (MODY)
01/19/1999 - "Improved metabolic control was associated with a significant (P=0.0001) reduction in 8-iso-PGF2alpha and TXM excretion by 32% and 41%, respectively, in 21 NIDDM patients. "
05/01/2001 - "The excretion of 8-iso-PGF(2alpha), was increased in type 2 diabetes mellitus compared to non-diabetic control subjects. "
05/01/2001 - "We studied the urinary excretion of 8-iso-PGF(2alpha) and related it to PON M/L55 genotypes in patients with type 2 diabetes mellitus (n = 55) and non-diabetic control subjects (n = 55). "
08/18/2000 - "Enhanced urinary excretion of 8-iso-PGF(2alpha) has been described in association with both type 1 and type 2 diabetes mellitus, and correlates with impaired glycemic control. "
07/17/1995 - "We found that the average concentration of esterified 8-epi-PGF2 alpha among NIDDM subjects (0.93 +/- 0.07 nM, n = 39) was higher (P < 0.0001, Mann-Whitney test) than in healthy individuals (0.28 +/- 0.04 nM, n = 15). "
|5.||Gastroesophageal Reflux (GERD)
01/01/2007 - "Two months of PPI therapy improved the pH (from 7.2 +/- 0.1 to 7.3 +/- 0.1) and the 8-isoprostane concentration (from 32.7 +/- 3.4 to 19.2 +/- 3.4) in the asthma patients with GERD, along with improvement of GERD symptoms. "
09/01/2009 - "There are still problems to be overcome before EBC can be used clinically, but pH and 8-isoprostane may be promising objective markers of airway inflammation due to GERD. "
09/01/2009 - "A decrease of pH and an increase of the 8-isoprostane concentration in EBC have been observed in patients with mild to moderate asthma accompanied by GERD. "
11/01/2007 - "Breath collected by cooling can be applied to pH, 8-isoprostane and cytokine analysis in patients with GERD-related asthma, and the pH and 8-isoprostane levels have been shown to reflect the effects of PPI therapy in these patients. "
01/01/2007 - "Measurement of the pH and 8-isoprostane level of exhaled breath condensate may be useful to evaluate the influence of GERD on asthma, as well as to determine the timing of intermittent PPI therapy."
|1.||Non-alcoholic Fatty Liver Disease
|5.||Transforming Growth Factor beta (TGF-beta)
|7.||Folic Acid (Vitamin M)
|1.||Drug Therapy (Chemotherapy)
|3.||Homologous Transplantation (Allograft)
|4.||Induced Heart Arrest (Cardioplegia)
|5.||Cardiopulmonary Resuscitation (CPR)